Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 20 - The Untold Story

Experts say there are a number of factors to weigh up about getting a fourth dose of a COVID-19

As millions more people become eligible for a fourth COVID vaccine dose, you might be asking whether you should book in for it or wait for Omicron-specific vaccines still being developed.

ABC News

Thinking of mixing and matching COVID-19 vaccine booster shots? There doesn't seem to be much point

Most people will have the Moderna or the Pfizer vaccine for their fourth dose. But the Doherty Institute's head of vaccine and immunisation research says there's practically no difference between them.

ABC News

Ministry signs contract to buy long-acting antibody drug

The Ministry of Public Health on Wednesday signed a procurement agreement with AstraZeneca for 257,500 doses of the long-acting antibody drug Evusheld, which boosts Covid-19 immunity in patients with low immunity levels.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Canada to throw out 13.6m AstraZeneca Covid vaccine doses amid lack of demand

Government pledged to donate millions of doses to other countries but they were ‘not accepted’ despite fresh rise in coronavirus cases around the world

The Guardian - AU

Canada throwing away 13.6m doses of AstraZeneca Covid vaccine that nobody wants

Oxford AstraZeneca vaccine fell out of favour amid concerns about rare but potentially fatal blood clots

Wales Online

Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Musk's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5

Reuters

Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine

Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc's (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents an expansion of the original master supply and development agreement announced between the two companies in September 2020. The manufacture of COVID-19 vaccines at Oxford Biomedica's Oxbox facility, as part of the…

Benzinga

Not just a number: families of five Australian pandemic victims reflect on loss during Covid

As Australia approaches the grim milestone of 10,000 Covid deaths, we look at the people behind the numbers

The Guardian - AU

Ian's 34yo daughter Katie died after receiving AstraZeneca's COVID-19 vaccine. He wants to honour her. But he also wants answers

The family of Katie Lees, who died after receiving a COVID-19 vaccine, say an arts fellowship in her name "lifts" them from being stuck in horror and grief, as they wait for clarity on an inquiry into the vaccine rollout.

ABC News

AstraZeneca Whale Trades For June 29

Someone with a lot of money to spend has taken a bearish stance on AstraZeneca (NASDAQ:AZN). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Vaccinologist Sarah Gilbert: ‘We need to be better prepared for a new pandemic’

The woman who co-developed the AstraZeneca vaccine on reassuring doubters, her new book and having a baby penguin named after her

The Guardian - UK

What Are Whales Doing With AstraZeneca

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Record

Woman becomes first to receive Covid vaccine compensation after fiancé's death

Vikki Spit lost her husband-to-be Zion after he fell ill on May 13, last year, just eight days after his vaccine appointment.

Daily Mirror

Dad 'paralysed' after rare Covid jab reaction wins £120,000 payout in 'horrendous' process

Anthony Shingler, 58, was handed the £120,000 tax-free payout on Tuesday after his wife, Nicola, applied for the Vaccine Damage Payment Scheme more than a year ago

Chronicle Live

Woman becomes first person to win Covid vaccine compensation after fiancé’s death

Vikki Spit claimed under the NHS Business Services Authority's Vaccine Damage Payment Scheme after her fiancé, Zion, 48, tragically died following the AstraZeneca jab

Daily Record

Dad 'paralysed by Covid vaccine' returns home after 420 days in hospital

Anthony Shingler claims to have suffered the rare side effect after receiving his first dose of the AstraZeneca vaccination.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

EU regulator authorizes COVID shot made by France's Valneva

The European Medicines Agency says it is recommending the authorization of the coronavirus vaccine made by French pharmaceutical Valneva, making it the sixth shot to be given the green light in Europe

Daily Mirror

Dad 'paralysed by Covid vaccine' in rare disorder leaves hospital after 420 days

Anthony Shingler, 58, was diagnosed with a very rare condition that affects the nerves and leaves around one in five people with long-term problems such as being unable to walk without assistance

Manchester Evening News

Woman gets £120,000 NHS payout after singer fiancé died following Covid jab

Vikki Split is believed to be the first Brit to receive vaccine damage payment compensation

Daily Mirror

Woman gets £120,000 payout from NHS after singer fiancé dies from Covid-19 jab

Vikki Spit, from Alston, Cumbria, filed for the claim under the NHS Business Services Authority's Vaccine Damage Payment Scheme after her fiancé Lord Zion died in May 2021

Benzinga

The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Conversation

Peer review: Can this critical step in the publication of science research be kinder?

Democracy has been called the least worst system of government. Peer review is the least worst system for assessing the merit of scientific work.

Benzinga

Why Mereo BioPharma Shares Are Jumping Today

AstraZeneca plc (NASDAQ:AZN) is rumored to be eyeing take over of Mereo BioPharma Group plc (NASDAQ:MREO), according to a report in The Times. The Times' report says that "Mereo would accept $5, equating to $500 million including American depositary receipts or ADRs. Evercore and Citigroup are said to be involved as advisers." Mereo's lead…

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.